Building Successful Partnerships in Animal Health Building Successful Partnerships in Animal Health Christoph Vetten, Head of Transactions Animal Health, shares his perspectives on how building successful collaborations can drive innovation.
Translational Medicine & Clinical Pharmacology Translational Medicine & Clinical Pharmacology We connect the right patient with the right drug on the right dosing schedule using data science methods from pharmacometrics to systems pharmacology.
3 Ways Boehringer Ingelheim's Corporate Values Align with Hispanic Heritage 3 Ways Boehringer Ingelheim's Corporate Values Align with Hispanic Heritage 3 Ways Boehringer Ingelheim's Corporate Values Align with Hispanic Heritage
Helping pets in hurricane-ravaged Puerto Rico Helping pets in hurricane-ravaged Puerto Rico Helping pets in hurricane-ravaged Puerto Rico
Creating an Inclusive Workplace for Employees with Disabilities Creating an Inclusive Workplace for Employees with Disabilities Creating an Inclusive Workplace for Employees with Disabilities
Boehringer Ingelheim Collaborates with Proxygen to Explore Molecular Glue Degraders - a Novel Approach to Fight Cancer Boehringer Ingelheim Collaborates with Proxygen to Explore Molecular Glue Degraders - a Novel Approach to Fight Cancer Boehringer Ingelheim Collaborates with Proxygen to Explore Molecular Glue Degraders - a Novel Approach to Fight Cancer
Animal Health Partnering Interests Animal Health Partnering Interests Learn about our Partnering Interests and how we can work together to advance innovation in animal health
Top-line Phase II Data for treatment of MASH Top-line Phase II Data for treatment of MASH Boehringer Ingelheim and Zealand Pharma announced top-line Phase II data for treatment of metabolic dysfuntion-associated steatohepatitis (MASH).
Low-WAC interchangeable biosimilar is now available Low-WAC interchangeable biosimilar is now available Adalimumab-adbm, our interchangeable biosimilar to Humira, now available at a low wholesale acquisition cost.
Galym Zhunisbekov Galym Zhunisbekov Galym Zhunisbekov, a Regional Regulatory Affairs Manager in Eastern Europe, talks about our philosophy and impact on patients’ lives.
A Planned Safety Net for Patients in Need A Planned Safety Net for Patients in Need A Planned Safety Net for Patients in Need
Facing Lung Cancer: Keith’s Story Facing Lung Cancer: Keith’s Story Facing Lung Cancer: Keith’s Story
R&D - Transforming tomorrow R&D - Transforming tomorrow Manami Tsutsumi, Senior Associate Director in Research & Development describes what it is like working on the cutting edge of pharmaceutical development.
BI Cares Financial Contributions Program BI Cares Financial Contributions Program BI Cares Financial Contributions Program
Welcome to Animal Health Partnering Welcome to Animal Health Partnering Welcome to Animal Health Partnering
Board of Managing Directors Board of Managing Directors Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities.